Idexx Laboratories (IDXX) Consolidated Net Income: 2009-2025
Historic Consolidated Net Income for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $274.6 million.
- Idexx Laboratories' Consolidated Net Income rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
- According to the latest figures from Q3 2025, Idexx Laboratories' Consolidated Net Income is $274.6 million, which was down 6.59% from $294.0 million recorded in Q2 2025.
- Over the past 5 years, Idexx Laboratories' Consolidated Net Income peaked at $294.0 million during Q2 2025, and registered a low of $132.0 million during Q2 2022.
- In the last 3 years, Idexx Laboratories' Consolidated Net Income had a median value of $224.2 million in 2023 and averaged $231.3 million.
- In the last 5 years, Idexx Laboratories' Consolidated Net Income soared by 82.64% in 2021 and then slumped by 34.86% in 2022.
- Quarterly analysis of 5 years shows Idexx Laboratories' Consolidated Net Income stood at $162.8 million in 2021, then grew by 5.80% to $172.2 million in 2022, then climbed by 12.96% to $194.5 million in 2023, then rose by 11.12% to $216.1 million in 2024, then increased by 17.94% to $274.6 million in 2025.
- Its Consolidated Net Income stands at $274.6 million for Q3 2025, versus $294.0 million for Q2 2025 and $242.7 million for Q1 2025.